INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Clinical trial NCT02386826 · COMPLETED

Trial details

NCT number: NCT02386826
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Gliosarcoma Colorectal Cancer Renal Cell Carcinoma

Start date: 2015-09-22
Primary completion: 2021-07-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.